These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 18175395)

  • 41. Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells.
    Ortiz-Ortiz MA; Morán JM; Ruiz-Mesa LM; Niso-Santano M; Bravo-SanPedro JM; Gómez-Sánchez R; González-Polo RA; Fuentes JM
    Neurosci Lett; 2010 Jan; 468(2):120-4. PubMed ID: 19879924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
    Trancikova A; Tsika E; Moore DJ
    Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.
    Schweitzer KJ; Brüssel T; Leitner P; Krüger R; Bauer P; Woitalla D; Tomiuk J; Gasser T; Berg D
    J Neurol; 2007 May; 254(5):613-6. PubMed ID: 17415511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular genetic pathways in Parkinson's disease: a review.
    Jain S; Wood NW; Healy DG
    Clin Sci (Lond); 2005 Oct; 109(4):355-64. PubMed ID: 16171459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2.
    Bras J; Guerreiro R; Ribeiro M; Morgadinho A; Januario C; Dias M; Calado A; Semedo C; Oliveira C; Hardy J; Singleton A
    BMC Neurol; 2008 Jan; 8():1. PubMed ID: 18211709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding the molecular causes of Parkinson's disease.
    Wood-Kaczmar A; Gandhi S; Wood NW
    Trends Mol Med; 2006 Nov; 12(11):521-8. PubMed ID: 17027339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease.
    Nishioka K; Kefi M; Jasinska-Myga B; Wider C; Vilariño-Güell C; Ross OA; Heckman MG; Middleton LT; Ishihara-Paul L; Gibson RA; Amouri R; Ben Yahmed S; Ben Sassi S; Zouari M; El Euch G; Farrer MJ; Hentati F
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):391-5. PubMed ID: 19726410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PINK1 mutations in a Brazilian cohort of early-onset Parkinson's disease patients.
    Godeiro-Junior C; de Carvalho-Aguiar PM; Felício AC; Barsottini OG; Silva SM; Borges V; Andrade LA; Ferraz HB
    Mov Disord; 2009 Aug; 24(11):1693-6. PubMed ID: 19562775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New insights into Parkinson's disease.
    Chung KK; Dawson VL; Dawson TM
    J Neurol; 2003 Oct; 250 Suppl 3():III15-24. PubMed ID: 14579120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetics of Parkinson's disease and parkinsonism.
    Douglas MR; Lewthwaite AJ; Nicholl DJ
    Expert Rev Neurother; 2007 Jun; 7(6):657-66. PubMed ID: 17563249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.
    Camargos ST; Dornas LO; Momeni P; Lees A; Hardy J; Singleton A; Cardoso F
    Mov Disord; 2009 Apr; 24(5):662-6. PubMed ID: 19205068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
    Sutherland GT; Halliday GM; Silburn PA; Mastaglia FL; Rowe DB; Boyle RS; O'Sullivan JD; Ly T; Wilton SD; Mellick GD
    Mov Disord; 2009 Apr; 24(6):833-8. PubMed ID: 19224617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
    Lesage S; Janin S; Lohmann E; Leutenegger AL; Leclere L; Viallet F; Pollak P; Durif F; Thobois S; Layet V; Vidailhet M; Agid Y; Dürr A; Brice A; ; Bonnet AM; Borg M; Broussolle E; Damier P; Destée A; Martinez M; Penet C; Rasco O; Tison F; Tranchan C; Vérin M
    Arch Neurol; 2007 Mar; 64(3):425-30. PubMed ID: 17353388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Parkinson's disease-related genes act in mitochondrial homeostasis.
    Sai Y; Zou Z; Peng K; Dong Z
    Neurosci Biobehav Rev; 2012 Oct; 36(9):2034-43. PubMed ID: 22771336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The genetics of Parkinson disease.
    Bekris LM; Mata IF; Zabetian CP
    J Geriatr Psychiatry Neurol; 2010 Dec; 23(4):228-42. PubMed ID: 20938043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetics and epigenetics of Parkinson's disease.
    Coppedè F
    ScientificWorldJournal; 2012; 2012():489830. PubMed ID: 22623900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular genetics of Parkinson's disease.
    Gasser T
    Adv Neurol; 2001; 86():23-32. PubMed ID: 11553982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Animal models for familial Parkinson's disease].
    Takahashi R
    Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects.
    Gasser T
    Prog Brain Res; 2010; 183():3-20. PubMed ID: 20696312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update on the pathogenesis of Parkinson's disease.
    Schulz JB
    J Neurol; 2008 Sep; 255 Suppl 5():3-7. PubMed ID: 18787877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.